100 related articles for article (PubMed ID: 26480818)
41. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
43. Sushi domain-containing protein 4 controls synaptic plasticity and motor learning.
González-Calvo I; Iyer K; Carquin M; Khayachi A; Giuliani FA; Sigoillot SM; Vincent J; Séveno M; Veleanu M; Tahraoui S; Albert M; Vigy O; Bosso-Lefèvre C; Nadjar Y; Dumoulin A; Triller A; Bessereau JL; Rondi-Reig L; Isope P; Selimi F
Elife; 2021 Mar; 10():. PubMed ID: 33661101
[TBL] [Abstract][Full Text] [Related]
44. Distinct expression profiles and functions of Kindlins in breast cancer.
Azorin P; Bonin F; Moukachar A; Ponceau A; Vacher S; Bièche I; Marangoni E; Fuhrmann L; Vincent-Salomon A; Lidereau R; Driouch K
J Exp Clin Cancer Res; 2018 Nov; 37(1):281. PubMed ID: 30477537
[TBL] [Abstract][Full Text] [Related]
45. The Complement Regulator Susd4 Influences Nervous-System Function and Neuronal Morphology in Mice.
Zhu H; Meissner LE; Byrnes C; Tuymetova G; Tifft CJ; Proia RL
iScience; 2020 Mar; 23(3):100957. PubMed ID: 32179479
[TBL] [Abstract][Full Text] [Related]
46. The role of complement inhibitors beyond controlling inflammation.
Blom AM
J Intern Med; 2017 Aug; 282(2):116-128. PubMed ID: 28345259
[TBL] [Abstract][Full Text] [Related]
47. Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis.
Watson AP; Evans RL; Egland KA
Mol Cancer Res; 2013 Jan; 11(1):74-85. PubMed ID: 23131994
[TBL] [Abstract][Full Text] [Related]
48. Tracking the Invasion of Small Numbers of Cells in Paper-Based Assays with Quantitative PCR.
Truong AS; Lochbaum CA; Boyce MW; Lockett MR
Anal Chem; 2015 Nov; 87(22):11263-70. PubMed ID: 26507077
[TBL] [Abstract][Full Text] [Related]
49. Novel potential inhibitors of complement system and their roles in complement regulation and beyond.
Gialeli C; Gungor B; Blom AM
Mol Immunol; 2018 Oct; 102():73-83. PubMed ID: 30217334
[TBL] [Abstract][Full Text] [Related]
50. [Molecular classification of breast cancer in Morocco].
Fouad A; Yousra A; Kaoutar Z; Omar el M; Afaf A; Sanae B
Pan Afr Med J; 2012; 13():91. PubMed ID: 23396646
[TBL] [Abstract][Full Text] [Related]
51. Impact of the discovery of membrane inhibitors of complement.
Atkinson JP
Res Immunol; 1996 Feb; 147(2):95-100. PubMed ID: 8792467
[No Abstract] [Full Text] [Related]
52. Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.
Escudero-Esparza A; Bartoschek M; Gialeli C; Okroj M; Owen S; Jirström K; Orimo A; Jiang WG; Pietras K; Blom AM
Oncotarget; 2023 May; 14():481-482. PubMed ID: 37204255
[No Abstract] [Full Text] [Related]
53. Pan-cancer analysis of Sushi domain-containing protein 4 (SUSD4) and validated in colorectal cancer.
Zhong Y; Zheng C; Zhang W; Wu H; Zhang Q; Li D; Ju H; Feng H; Chen Y; Fan Y; Chen W; Wang M; Wang G
Aging (Albany NY); 2024 Apr; 16(7):6417-6444. PubMed ID: 38579174
[TBL] [Abstract][Full Text] [Related]
54. Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner.
Papadakos KS; Ekström A; Slipek P; Skourti E; Reid S; Pietras K; Blom AM
J Exp Clin Cancer Res; 2022 Dec; 41(1):363. PubMed ID: 36578014
[TBL] [Abstract][Full Text] [Related]
55. CBX3 is a Prognostic Biomarker Correlated with ATR Activation and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Zhang X; Zhou W; Zhang Y; Liu Z
Int J Gen Med; 2022; 15():1497-1508. PubMed ID: 35210823
[TBL] [Abstract][Full Text] [Related]
56. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W
Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296
[TBL] [Abstract][Full Text] [Related]
57. Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis.
Englund E; Canesin G; Papadakos KS; Vishnu N; Persson E; Reitsma B; Anand A; Jacobsson L; Helczynski L; Mulder H; Bjartell A; Blom AM
Oncotarget; 2017 Nov; 8(58):98298-98311. PubMed ID: 29228690
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
59. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.
Englund E; Bartoschek M; Reitsma B; Jacobsson L; Escudero-Esparza A; Orimo A; Leandersson K; Hagerling C; Aspberg A; Storm P; Okroj M; Mulder H; Jirström K; Pietras K; Blom AM
Oncogene; 2016 Oct; 35(43):5585-5596. PubMed ID: 27065333
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
